Expert Opinion on Investigational Drugs

Targeting the nerve growth factor network in Alzheimer's disease
pp. 267-269(3)
Authors: Sykiotis, Gerasimos P; Papavassiliou, Athanasios G

Beyond heparin and warfarin: the new generation of anticoagulants
pp. 271-282(12)
Authors: Weitz, Jeffrey I; Linkins, Lori-Ann

FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis
pp. 283-289(7)
Authors: Baumruker, Thomas; Billich, Andreas; Brinkmann, Volker

α-Lipoic acid: physiologic mechanisms and indications for the treatment of metabolic syndrome
pp. 291-302(12)
Author: Pershadsingh, Harrihar A

Manipulation of the nerve growth factor network in prostate cancer
pp. 303-309(7)
Authors: Papatsoris, Athanasios G; Liolitsa, Danae; Deliveliotis, Charalambos

The new paradigm in the treatment of colorectal cancer: are we hitting the right target?
pp. 311-324(14)
Authors: Baranda, Joaquina; Williamson, Stephen

Investigational agents against platinum-resistant ovarian cancer
pp. 325-336(12)
Authors: Lorusso, Domenica; Ferrandina, Gabriella; Fanfani, Francesco; Gagliardi, Maria Lucia; Scambia, Giovanni

Emerging drug therapies for preventing spontaneous preterm labor and preterm birth
pp. 337-345(9)
Authors: Lamont, Ronald F; Jaggat, Anilla N

Telavancin: a novel lipoglycopeptide for serious Gram-positive infections
pp. 347-357(11)
Authors: Laohavaleeson, Somvadee; Kuti, Joseph L; Nicolau, David P

PTI-821: sustained-release oxycodone using gel-cap technology
pp. 359-366(8)
Author: Webster, Lynn R

Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours
pp. 367-379(13)
Authors: Scott, Edwina N; Meinhardt, Gerold; Jacques, Christian; Laurent, Dirk; Thomas, Anne L

Clinical activity of tipifarnib in hematologic malignancies
pp. 381-392(12)
Authors: Jabbour, Elias; Kantarjian, Hagop; Cortes, Jorge

Cyclophosphamide for scleroderma interstitial lung disease
pp. 393-395(3)
Author: Antoniu, Sabina A

3^rd PacRim Breast and Prostate Cancer Meeting
pp. 397-401(5)
Author: Fuller, Peter J